Search


Current filters:


Start a new search
Add filters:

Use filters to refine the search results.


Results 1-10 of 11 (Search time: 0.002 seconds).
Item hits:
PreviewIssue DateTitleAuthor(s)
2006Circulating steroid hormones and the risk of prostate cancerSeveri, G.; Morris, H.; MacInnes, R.; English, D.; Tilley, W.; Hopper, J.; Boyle, P.; Giles, G.
20075 α-Reductase type 2 gene variant associations with prostate cancer risk, circulating hormone levels and androgenetic alopeciaHayes, V.; Severi, G.; Padilla, E.; Morris, H.; Tilley, W.; Southey, M.; English, D.; Sutherland, R.; Hopper, J.; Boyle, P.; Giles, G.
2008Elevated levels of HER-2/neu and androgen receptor in clinically localized prostate cancer identifies metastatic potentialRicciardelli, C.; Jackson, M.; Choong, C.; Stahl, J.; Marshall, V.; Horsfall, D.; Tilley, W.
2011Specific medical conditions associated with clinically significant depressive symptoms in menAtlantis, E.; Lange, K.; Goldney, R.; Martin, S.; Haren, M.; Taylor, A.; O'Loughlin, P.; Marshall, V.; Tilley, W.; Wittert, G.
2010Serum testosterone bioassay evaluation in a large male cohortNeed, E.; O'Loughlin, P.; Armstrong, D.; Haren, M.; Martin, S.; Tilley, W.; Wittert, G.; Buchanan, G.
2003ELAC2/HPC2 polymorphisms, prostate-specific antigen levels, and prostate cancerSeveri, G.; Giles, G.; Southey, M.; Tesoriero, A.; Tilley, W.; Neufing, P.; Morris, H.; English, D.; McCredie, M.; Boyle, P.; Hopper, J.
2006Circulating insulin-like growth factor-I and binding protein-3 and risk of prostate cancerSeveri, G.; Morris, H.; MacInnis, R.; English, D.; Tilley, W.; Hopper, J.; Boyle, P.; Giles, G.
2010Comparative biomarker expression and RNA integrity in biospecimens derived from radical retropubic and robot-assisted laparoscopic prostatectomiesRicciardelli, C.; Bianco-Miotto, T.; Jindal, S.; Dodd, T.; Cohen, P.; Marshall, V.; Sutherland, P.; Samaratunga, H.; Kench, J.; Dong, Y.; Wang, H.; Clements, J.; Risbridger, G.; Sutherland, R.; Tilley, W.; Horsfall, D.
2012Evidence for efficacy of new Hsp90 inhibitors revealed by ex vivo culture of human prostate tumorsCentenera, M.; Gillis, J.; Hanson, A.; Jindal, S.; Taylor, R.; Risbridger, G.; Sutherland, P.; Scher, H.; Raj, G.; Knudsen, K.; Yeadon, T.; Tilley, W.; Butler, L.
2006Variants in the prostate-specific antigen (PSA) gene and prostate cancer risk, survival, and circulating PSASeveri, G.; Hayes, V.; Neufing, P.; Padilla, E.; Tilley, W.; Eggleton, S.; Morris, H.; English, D.; Southey, M.; Hopper, J.; Sutherland, R.; Boyle, P.; Giles, G.